New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
10:13 EDTLGNDLundbeck announces FDA acceptance of NDA submission for Carbamazepine IV
Captisol licensee Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug carbamazepine. An action letter is anticipated before the end of 2014. Carbella Injection is the proposed U.S. trade name. With acceptance of the NDA filing, Ligand earns a $200,000 milestone payment.
News For LGND From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 27, 2015
09:15 EDTLGNDLigand management to meet with Craig Hallum
Meeting to be held in Kansas City on May 28 hosted by Craig Hallum.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use